Functional Models of Neural Circuits for Pathophysiology of Major Depressive Disorder

被引:0
|
作者
Mumtaz, Wajid [1 ]
Xia, Likun [1 ]
Malik, Aamir Saeed [1 ]
Yasin, Mohd Azhar Mohd [2 ]
机构
[1] Univ Teknol PETRONAS, CISIR, Elect & Elect Engn, Tronoh 31750, Perak, Malaysia
[2] Univ Sains Malaysia, Dept Psychiat, Kelantan, Malaysia
关键词
Major depressive disorder (MDD); functional connectivity; effective connectivity; electroencephalography (EEG); functional magnatic resonance Imaging (fMRI); CONNECTIVITY;
D O I
暂无
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Human brain is a complex system with dynamic responses. Intercommunication of brain regions to perform a real world task results into unique functional models based on activation of brain regions and strength of their interconnectivity. The functional models may be studied under the categories of anatomical, effective and functional connectivity. Variability of these models under same conditions signifies pathophysiology of a psychotic disease. Functional model of an abnormal brain has a different physiological connectivity pattern as compared to a normal one. Identification of these abnormalities may have useful implications for clinical diagnosis and prognosis. It may also be helpful in prediction of treatment response of an antidepressant. This paper provides description of functional models for pathophysiology of major depressive disorder (MDD) using functional magnetic resonance imaging (fMRI).
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [1] Neural circuits underlying anhedonia in major depressive disorder
    Drevets, Wayne C.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 35S - 35S
  • [2] Application of neural mass models to major depressive disorder
    Natalia Z Bielczyk
    BMC Neuroscience, 14 (Suppl 1)
  • [3] Neural circuits mediating chronic stress: Implications for major depressive disorder
    Guo, Hongling
    Ali, Tahir
    Li, Shupeng
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 137
  • [4] Cytokine imbalance in the pathophysiology of major depressive disorder
    Kim, Yong-Ku
    Na, Kyeong-Sae
    Shin, Kyung-Ho
    Jung, Han-Yong
    Choi, So-Hyun
    Kim, Jung-Bum
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2007, 31 (05): : 1044 - 1053
  • [5] The Role of Chemokines in the Pathophysiology of Major Depressive Disorder
    Milenkovic, Vladimir M.
    Stanton, Evan H.
    Nothdurfter, Caroline
    Rupprecht, Rainer
    Wetzel, Christian H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [6] The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
    Amidfar, Meysam
    Reus, Gislaine Zilli
    de Moura, Airam Barbosa
    Quevedo, Joao
    Kim, Yong-Ku
    MAJOR DEPRESSIVE DISORDER: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES, 2021, 1305 : 257 - 272
  • [7] Cortical Inhibition in the Pathophysiology and Treatment of Major Depressive Disorder
    Voineskos, Daphne
    Levinson, Andrea
    Blumberger, Daniel
    Sun, YinMing
    Farzan, Faranak
    Daskalakis, Zafiris J.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 139S - 139S
  • [8] Emerging role of glutamate in the pathophysiology of major depressive disorder
    Hashimoto, Kenji
    BRAIN RESEARCH REVIEWS, 2009, 61 (02) : 105 - 123
  • [9] Investigating neural circuits of emotion regulation to distinguish euthymic patients with bipolar disorder and major depressive disorder
    Rai, Sabina
    Griffiths, Kristi
    Breukelaar, Isabella A.
    Barreiros, Ana R.
    Chen, Wenting
    Boyce, Philip
    Hazell, Philip
    Foster, Sheryl
    Malhi, Gin S.
    Bryant, Richard A.
    Harris, Anthony W. F.
    Korgaonkar, Mayuresh S.
    BIPOLAR DISORDERS, 2021, 23 (03) : 284 - 294
  • [10] Functional consequences of major depressive disorder
    Hammer-Helmich, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S1134 - S1134